AU689250B2
(en)
|
1994-04-22 |
1998-03-26 |
Astellas Pharma Inc. |
Colon-specific drug release system
|
DK0859612T3
(da)
*
|
1995-09-21 |
2003-09-22 |
Pharma Pass Ii Llc |
Farmaceutisk sammensætning indeholdende en syre-labil omeprazol og fremgangsmåde til fremstilling deraf
|
US6231888B1
(en)
*
|
1996-01-18 |
2001-05-15 |
Perio Products Ltd. |
Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
|
WO1998005310A1
(fr)
*
|
1996-08-02 |
1998-02-12 |
Hisamitsu Pharmaceutical Co., Inc. |
Gelules destinees a des preparations orales et preparations de gelules destinees a une administration orale
|
SE9604751D0
(sv)
*
|
1996-12-20 |
1996-12-20 |
Astra Ab |
New therapy
|
GB9720797D0
(en)
*
|
1997-09-30 |
1997-12-03 |
Rhodes John |
Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
|
WO1999018938A1
(en)
*
|
1997-10-09 |
1999-04-22 |
Perio Products Ltd. |
Delayed total release gastrointestinal drug delivery system
|
US6350470B1
(en)
*
|
1998-04-29 |
2002-02-26 |
Cima Labs Inc. |
Effervescent drug delivery system for oral administration
|
EP1079810B1
(de)
*
|
1998-04-22 |
2004-06-16 |
Glycologic Limited |
Oral anwendbare zubereitungen enthaltend ein kationvernetztes polysaccharid und ein im unteren intestinalen bereich abbaubares polymer
|
US7022683B1
(en)
|
1998-05-13 |
2006-04-04 |
Carrington Laboratories, Inc. |
Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
|
ES2274625T3
(es)
|
1998-05-18 |
2007-05-16 |
Takeda Pharmaceutical Company Limited |
Comprimidos desintegrables en la boca que comprenden un bencimidazol.
|
SI1077722T1
(sl)
|
1998-05-22 |
2007-02-28 |
Ottawa Health Research Inst |
Metode in produkti za induciranje sluznicne imunosti
|
AU4802099A
(en)
|
1998-07-28 |
2000-02-21 |
Takeda Chemical Industries Ltd. |
Rapidly disintegrable solid preparation
|
AU772726B2
(en)
*
|
1998-08-12 |
2004-05-06 |
Takeda Gmbh |
Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
|
US6387410B1
(en)
*
|
1998-09-10 |
2002-05-14 |
Norton Healthcare Ltd |
Anti-inflammatory pharmaceutical formulations
|
US6514525B2
(en)
|
1998-09-10 |
2003-02-04 |
Norton Healthcare Ltd |
Anti-inflammatory pharmaceutical formulations
|
US6645192B2
(en)
*
|
1998-09-30 |
2003-11-11 |
Ivy Animal Health, Inc. |
Pellet implant system for immediate and delayed release of antiparasitic drug
|
US6531152B1
(en)
*
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
US20090149479A1
(en)
*
|
1998-11-02 |
2009-06-11 |
Elan Pharma International Limited |
Dosing regimen
|
US20060240105A1
(en)
*
|
1998-11-02 |
2006-10-26 |
Elan Corporation, Plc |
Multiparticulate modified release composition
|
CA2348871C
(en)
*
|
1998-11-02 |
2009-04-14 |
John G. Devane |
Multiparticulate modified release composition
|
AR023700A1
(es)
*
|
1998-11-12 |
2002-09-04 |
Smithkline Beecham Plc |
Un procedimiento para preparar una composicion farmaceutica que comprende un sensibilizador de insulina
|
SA99191255B1
(ar)
|
1998-11-30 |
2006-11-25 |
جي دي سيرل اند كو |
مركبات سيليكوكسيب celecoxib
|
US6432448B1
(en)
*
|
1999-02-08 |
2002-08-13 |
Fmc Corporation |
Edible coating composition
|
US6723342B1
(en)
|
1999-02-08 |
2004-04-20 |
Fmc Corporation |
Edible coating composition
|
US6351665B1
(en)
|
1999-05-07 |
2002-02-26 |
Kenneth L Koch |
Method and apparatus for evaluating myoelectric signals and identifying artifact
|
US6632451B2
(en)
*
|
1999-06-04 |
2003-10-14 |
Dexcel Pharma Technologies Ltd. |
Delayed total release two pulse gastrointestinal drug delivery system
|
EP1184038B1
(de)
*
|
1999-06-09 |
2005-12-28 |
Mochida Pharmaceutical Co., Ltd. |
System für wirkstofffreisetzung im unteren verdauungstrakt
|
ATE251449T1
(de)
|
1999-06-14 |
2003-10-15 |
Cosmo Spa |
Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
|
US8895064B2
(en)
|
1999-06-14 |
2014-11-25 |
Cosmo Technologies Limited |
Controlled release and taste masking oral pharmaceutical composition
|
SE9902386D0
(sv)
*
|
1999-06-22 |
1999-06-22 |
Astra Ab |
New formulation
|
US20040258750A1
(en)
*
|
1999-06-28 |
2004-12-23 |
Gerard Alaux |
Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
|
EP1064938A1
(de)
*
|
1999-06-28 |
2001-01-03 |
Sanofi-Synthelabo |
Pharmazeutische Dosierungsformen zur kontrollierte Wirkstoffabgabe mit mindenstens ein pulsierendem Zeitverlauf
|
KR20020015721A
(ko)
*
|
1999-08-09 |
2002-02-28 |
도모따께 다께시 |
키토산 분말 함유 고형 제제 및 그의 제조방법
|
MXPA02004293A
(es)
|
1999-10-29 |
2002-10-31 |
Euro Celtique Sa |
Formulaciones de hidrocodona de liberacion controlada..
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
US6500462B1
(en)
|
1999-10-29 |
2002-12-31 |
Fmc Corporation |
Edible MCC/PGA coating composition
|
IL133196A0
(en)
*
|
1999-11-29 |
2001-03-19 |
Yissum Res Dev Co |
Gastroretentive controlled release pharmaceutical dosage forms
|
US7771746B2
(en)
*
|
1999-12-03 |
2010-08-10 |
Polichem Sa |
Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof
|
DE19961897A1
(de)
*
|
1999-12-20 |
2001-06-28 |
Basf Ag |
Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen
|
NZ518281A
(en)
*
|
1999-12-23 |
2005-01-28 |
Pfizer Prod Inc |
Controlled release drug dosage core comprising a drug-containing composition and a water-swellable composition
|
CA2395231C
(en)
|
1999-12-23 |
2006-08-15 |
Pfizer Products Inc. |
Hydrogel-driven layered drug dosage form
|
US6451345B1
(en)
*
|
2000-01-20 |
2002-09-17 |
Eurand Pharmaceuticals Ltd. |
Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
|
AU767812B2
(en)
|
2000-02-04 |
2003-11-27 |
Depomed, Inc. |
Shell-and-core dosage form approaching zero-order drug release
|
IN192159B
(de)
*
|
2000-05-15 |
2004-02-28 |
Ranbaxy Lab Ltd |
|
CN1141974C
(zh)
|
2000-06-07 |
2004-03-17 |
张昊 |
结肠定位释放的口服生物制剂
|
CN1285333C
(zh)
*
|
2000-06-07 |
2006-11-22 |
张昊 |
结肠定位释放的口服制剂及其制备方法
|
IL137431A0
(en)
|
2000-07-20 |
2001-07-24 |
Slo Flo Ltd |
A new slow release device for controlled delivery of liquid material
|
KR100411195B1
(ko)
*
|
2000-09-26 |
2003-12-18 |
한국화학연구원 |
케토롤락 트로메타민이 함유된 서방형 펠렛
|
EP1337244A4
(de)
|
2000-10-30 |
2006-01-11 |
Euro Celtique Sa |
Hydrocodon-formulierungen mit kontrollierter freisetzung
|
US6932861B2
(en)
*
|
2000-11-28 |
2005-08-23 |
Fmc Corporation |
Edible PGA coating composition
|
TR200300731T2
(tr)
|
2000-11-28 |
2004-08-23 |
Fmc Corporation |
Yenebilir PGA kaplama bileşimi
|
US6777000B2
(en)
|
2001-02-28 |
2004-08-17 |
Carrington Laboratories, Inc. |
In-situ gel formation of pectin
|
US7494669B2
(en)
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
US7316819B2
(en)
*
|
2001-03-08 |
2008-01-08 |
Unigene Laboratories, Inc. |
Oral peptide pharmaceutical dosage form and method of production
|
AU2002313628A1
(en)
*
|
2001-05-22 |
2002-12-03 |
Euro-Celtique |
Tamper resistant oral dosage form
|
WO2003002100A1
(en)
*
|
2001-06-26 |
2003-01-09 |
Farrell John J |
Tamper-proof narcotic delivery system
|
US20030091630A1
(en)
*
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
CA2409552A1
(en)
*
|
2001-10-25 |
2003-04-25 |
Depomed, Inc. |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
US20030152622A1
(en)
*
|
2001-10-25 |
2003-08-14 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral diuretic
|
US20030104052A1
(en)
*
|
2001-10-25 |
2003-06-05 |
Bret Berner |
Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
|
US7045549B2
(en)
|
2001-11-08 |
2006-05-16 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Treatment of symptoms associated with irritable bowel syndrome
|
US7550156B2
(en)
|
2001-11-23 |
2009-06-23 |
Rohm And Haas Company |
Optimised pellet formulations
|
MXPA04006163A
(es)
*
|
2001-12-20 |
2004-11-01 |
Pharmacia Corp |
Formas de dosis de liberacion sostenida del orden-cero y metodo de fabricacion de las mismas.
|
EP1327450B1
(de)
*
|
2002-01-15 |
2007-08-15 |
Bio Life Science Forschungs- und Entwicklungsges.m.b.H. |
Orale Vakzinierung mit nackten Tumor-Antigen-Mimotopen
|
IL162857A0
(en)
*
|
2002-01-15 |
2005-11-20 |
Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh |
Oral vaccination
|
WO2003062199A2
(en)
*
|
2002-01-16 |
2003-07-31 |
Agency For Disease Diagnosis And Prevention |
Pace-a microspheres for delivery of antigens
|
CN1993109A
(zh)
*
|
2002-03-05 |
2007-07-04 |
兰贝克赛实验室有限公司 |
释放得到改良的口服药物组合物
|
US20040156844A1
(en)
*
|
2002-05-22 |
2004-08-12 |
Curtis Wright |
Tamper resistant oral dosage form
|
US6986901B2
(en)
|
2002-07-15 |
2006-01-17 |
Warner-Lambert Company Llc |
Gastrointestinal compositions
|
US7985422B2
(en)
*
|
2002-08-05 |
2011-07-26 |
Torrent Pharmaceuticals Limited |
Dosage form
|
FR2843872B1
(fr)
|
2002-08-29 |
2005-08-19 |
C T M Ct De Transfert Des Micr |
Dispositif de localisation equipant une capsule intestinale
|
US20040062778A1
(en)
*
|
2002-09-26 |
2004-04-01 |
Adi Shefer |
Surface dissolution and/or bulk erosion controlled release compositions and devices
|
US6703044B1
(en)
*
|
2002-10-25 |
2004-03-09 |
Dexcel Pharma Tech, Ltd |
Venlafaxine formulations
|
JP2006507298A
(ja)
*
|
2002-10-30 |
2006-03-02 |
ファルマシア コーポレーション |
経口持続放出型錠剤、ならびにその製造法および使用法
|
US9561182B2
(en)
|
2003-08-22 |
2017-02-07 |
Cure Pharmaceutical Corporation |
Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals
|
CN1322865C
(zh)
*
|
2002-11-14 |
2007-06-27 |
北京东方凯恩医药科技有限公司 |
用于治疗菌痢的口服结肠定位给药组合物
|
US20040096497A1
(en)
*
|
2002-11-19 |
2004-05-20 |
Ponder Garratt W. |
Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions
|
US8519008B2
(en)
|
2003-01-22 |
2013-08-27 |
Purina Animal Nutrition Llc |
Method and composition for improving the health of young monogastric mammals
|
US20050147663A1
(en)
*
|
2003-07-17 |
2005-07-07 |
Mohan Mailatur S. |
Method of treatment for improved bioavailability
|
RU2375048C2
(ru)
*
|
2003-07-17 |
2009-12-10 |
Д-Р Редди'С Лабораторис Инк. |
Фармацевтическая композиция с набухающим покрытием
|
US7825106B2
(en)
|
2003-09-03 |
2010-11-02 |
Agi Therapeutics Ltd. |
Modified release formulations and methods of treating inflammatory bowel disease
|
US7737133B2
(en)
*
|
2003-09-03 |
2010-06-15 |
Agi Therapeutics Ltd. |
Formulations and methods of treating inflammatory bowel disease
|
KR100782918B1
(ko)
*
|
2003-09-19 |
2007-12-07 |
펜웨스트 파머슈티칼즈 컴파니 |
지연 방출성 제형
|
EP1682537B1
(de)
|
2003-11-05 |
2012-03-28 |
SARcode Bioscience Inc. |
Modulatoren der zellulären adhäsion
|
US20050175695A1
(en)
*
|
2003-11-25 |
2005-08-11 |
Catherine Castan |
Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
|
EP1718148A2
(de)
*
|
2004-02-03 |
2006-11-08 |
The Regents of the University of California |
Verfahren zur behandlung von reizdarmsyndrom
|
CA2568542A1
(en)
*
|
2004-05-27 |
2005-12-08 |
Dexcel Pharma Technologies Ltd. |
Localized controlled absorption of statins in the gastrointestinal tract for achieving high blood levels of statins
|
WO2006054307A2
(en)
*
|
2004-11-22 |
2006-05-26 |
Dexcel Pharma Technologies Ltd. |
Controlled absorption of statins in the intestine
|
CA2588216A1
(en)
*
|
2004-11-22 |
2006-05-26 |
Dexcel Pharma Technologies Ltd. |
Stable atorvastatin formulations
|
FR2878159B1
(fr)
*
|
2004-11-24 |
2008-10-17 |
Flamel Technologies Sa |
Medicament oral a liberation modifiee d'au moins un principe actif sous forme multimicrocapsulaire
|
US20060121112A1
(en)
*
|
2004-12-08 |
2006-06-08 |
Elan Corporation, Plc |
Topiramate pharmaceutical composition
|
JP2008525313A
(ja)
|
2004-12-27 |
2008-07-17 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
抗痴呆薬の安定化方法
|
US20060159753A1
(en)
*
|
2004-12-27 |
2006-07-20 |
Eisai Co. Ltd. |
Matrix type sustained-release preparation containing basic drug or salt thereof
|
EP1846042A2
(de)
*
|
2005-01-05 |
2007-10-24 |
Board of Regents, The University of Texas System |
Konjugate zur doppelten abbildung und radiochemotherapie: zusammensetzung sowie herstellung und anwendungen davon
|
SI1698630T1
(sl)
|
2005-03-03 |
2015-01-30 |
Alfa Wassermann S.P.A. |
Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih
|
ITBO20050123A1
(it)
*
|
2005-03-07 |
2005-06-06 |
Alfa Wassermann Spa |
Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
|
CA2601800C
(en)
*
|
2005-03-14 |
2013-12-03 |
Nitin Bhalachandra Dharmadhikari |
Oral drug delivery system
|
WO2006103661A2
(en)
*
|
2005-03-28 |
2006-10-05 |
Dexcel Pharma Technologies Ltd. |
Controlled absorption of statins in the intestine
|
KR20080007586A
(ko)
*
|
2005-04-12 |
2008-01-22 |
엘란 파마 인터내셔널 리미티드 |
세균감염증의 치료를 위한 세팔로스포린 함유 조절 방출조성물
|
ES2614080T3
(es)
*
|
2005-05-17 |
2017-05-29 |
Sarcode Bioscience Inc. |
Composiciones y métodos para el tratamiento de trastornos oculares
|
US20060280795A1
(en)
|
2005-06-08 |
2006-12-14 |
Dexcel Pharma Technologies, Ltd. |
Specific time-delayed burst profile delivery system
|
US8778395B2
(en)
*
|
2005-08-11 |
2014-07-15 |
Andrx Labs, Llc |
Diltiazem controlled release formulation and method of manufacture
|
US20070082029A1
(en)
*
|
2005-10-07 |
2007-04-12 |
Aimutis William R |
Fiber satiety compositions
|
US20070082027A1
(en)
*
|
2005-10-07 |
2007-04-12 |
Aimutis William R Jr |
Compositions and methods for reducing food intake and controlling weight
|
US8497258B2
(en)
|
2005-11-12 |
2013-07-30 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
CA2656411A1
(en)
|
2006-06-28 |
2008-01-03 |
Surmodics, Inc. |
Combination degradable and non-degradable matrices for active agent delivery
|
MY149863A
(en)
|
2006-08-03 |
2013-10-31 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of rheumatoid disease
|
US8889184B2
(en)
*
|
2006-09-07 |
2014-11-18 |
Losan Pharma Gmbh |
Particulate form of a pharmaceutical composition which is easy to swallow
|
EP2079448A2
(de)
*
|
2006-10-10 |
2009-07-22 |
Dexcel Pharma Technologies Ltd. |
Verbesserte freisetzung von statinen im darm
|
EP2081557A1
(de)
*
|
2006-11-17 |
2009-07-29 |
DA Volterra |
Abgabe im kolon mit zn/pectin-perlen mit eudragit-beschichtung
|
US8273376B2
(en)
|
2006-11-17 |
2012-09-25 |
Da Volterra |
Colonic delivery of metallo-dependent enzymes
|
US20080260823A1
(en)
*
|
2007-04-20 |
2008-10-23 |
Sciele Pharma, Inc. |
Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
|
US20090036414A1
(en)
*
|
2007-08-02 |
2009-02-05 |
Mutual Pharmaceutical Company, Inc. |
Mesalamine Formulations
|
US20100239682A1
(en)
*
|
2007-09-17 |
2010-09-23 |
Antoine Andremont |
Colonic delivery of antimicrobial agents
|
EP3797775A1
(de)
|
2007-10-19 |
2021-03-31 |
Novartis AG |
Zusammensetzungen und verfahren zur behandlung von diabetischer retinopathie
|
US8865692B2
(en)
|
2007-11-13 |
2014-10-21 |
Meritage Pharma, Inc |
Compositions for the treatment of gastrointestinal inflammation
|
US20100216754A1
(en)
*
|
2007-11-13 |
2010-08-26 |
Meritage Pharma, Inc. |
Compositions for the treatment of inflammation of the gastrointestinal tract
|
EP3574914B1
(de)
|
2007-11-13 |
2021-12-29 |
ViroPharma Biologics LLC |
Kortikosteroidzusammensetzungen
|
US20090169622A1
(en)
*
|
2007-12-27 |
2009-07-02 |
Roxane Laboratories, Inc. |
Delayed-release oral pharmaceutical composition for treatment of colonic disorders
|
WO2009139817A2
(en)
|
2008-04-15 |
2009-11-19 |
Sarcode Corporation |
Crystalline pharmaceutical and methods of preparation and use thereof
|
ES2425762T3
(es)
*
|
2008-10-27 |
2013-10-17 |
Roquette Freres |
Polímero insoluble en agua: revestimientos de película a base de derivados de almidón modificado para la liberación dirigida al colon
|
NZ582836A
(en)
*
|
2009-01-30 |
2011-06-30 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of rheumatoid arthritis by improving signs and symptoms, showing major or complete clinical response and by preventing from joint damage
|
US8945616B2
(en)
*
|
2009-02-17 |
2015-02-03 |
Mylan Pharmaceuticals Inc. |
Controlled release budesonide minitablets
|
US8945615B2
(en)
*
|
2009-02-17 |
2015-02-03 |
Mylan Pharmaceuticals Inc. |
Controlled release budesonide minitablets
|
CA2754604A1
(en)
*
|
2009-03-13 |
2010-09-16 |
Da Volterra |
Compositions and methods for elimination of gram-negative bacteria
|
EP2440210A4
(de)
*
|
2009-06-12 |
2014-01-29 |
Meritage Pharma Inc |
Verfahren zur behandlung von magen-darm-erkrankungen
|
WO2011050175A1
(en)
|
2009-10-21 |
2011-04-28 |
Sarcode Corporation |
Crystalline pharmaceutical and methods of preparation and use thereof
|
IT1398550B1
(it)
|
2010-03-05 |
2013-03-01 |
Alfa Wassermann Spa |
Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
|
WO2011160062A2
(en)
|
2010-06-17 |
2011-12-22 |
The Usa As Represented By The Secretary, National Institutes Of Health |
Compositions and methods for treating inflammatory conditions
|
US8911780B2
(en)
|
2011-02-11 |
2014-12-16 |
Zx Pharma, Llc |
Multiparticulate L-menthol formulations and related methods
|
US8808736B2
(en)
|
2011-02-11 |
2014-08-19 |
Zx Pharma, Llc |
Enteric coated multiparticulate controlled release peppermint oil composition and related methods
|
CN103442727B
(zh)
|
2011-02-11 |
2016-08-10 |
Zx制药有限责任公司 |
多微粒l-薄荷醇制剂及相关方法
|
BR112013029199B1
(pt)
|
2011-05-13 |
2022-02-08 |
Eb Ip Hybritabs B.V. |
Dispositivo de distribuição de dois fármacos
|
ITBO20110461A1
(it)
|
2011-07-29 |
2013-01-30 |
Alfa Wassermann Spa |
Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
|
US10154964B2
(en)
|
2011-09-07 |
2018-12-18 |
Cosmo Technologies Limited |
Controlled release and taste masking oral pharmaceutical composition
|
ITBO20120368A1
(it)
|
2012-07-06 |
2014-01-07 |
Alfa Wassermann Spa |
Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
|
CN104797574B
(zh)
|
2012-07-25 |
2019-11-22 |
原生质生物科学股份有限公司 |
Lfa-1抑制剂及其多晶型物
|
US20140066837A1
(en)
|
2012-07-26 |
2014-03-06 |
Ronald L. Moy |
Skin care compositions and methods
|
US9289418B2
(en)
|
2013-03-15 |
2016-03-22 |
Cedars-Sinai Medical Center |
Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
|
EP2967060A4
(de)
|
2013-03-15 |
2016-11-23 |
Cedars Sinai Medical Center |
Verfahren zur diagnose, auswahl und behandlung von erkrankungen und zuständen durch oder in zusammenhang mit methanogenen
|
EP2978416B1
(de)
*
|
2013-03-26 |
2016-10-26 |
Lipid Therapeutics GmbH |
Pharmazeutische formulierung mit phosphatidylcholin zur behandlung von colitis ulcerosa
|
RS58325B1
(sr)
|
2013-04-23 |
2019-03-29 |
Zx Pharma Llc |
Enterosolventno obloženi višečestični preparat sa proteinskom sub-oblogom
|
PL3546464T3
(pl)
|
2014-05-12 |
2020-11-02 |
Alfasigma S.P.A. |
Sposób wytwarzania i zastosowanie postaci krystalicznej Tau rifaksyminy solwatowanej z DEGME
|
BR112016028957B1
(pt)
|
2014-06-11 |
2021-12-14 |
The Brigham And Women's Hospital, Inc. |
Estrutura de residência gástrica
|
US20170266112A1
(en)
|
2014-06-11 |
2017-09-21 |
Massachusetts Institute Of Technology |
Residence structures and related methods
|
EP3179983A4
(de)
|
2014-08-13 |
2018-01-10 |
Cedars-Sinai Medical Center |
Anti-methanogene zusammensetzungen und verwendungen davon
|
US20160158174A1
(en)
*
|
2014-12-09 |
2016-06-09 |
Intercontinental Great Brands Llc |
Enteric-Coated Functional Food Ingredients And Methods For Making The Enteric-Coated Functional Food Ingredients
|
US10736871B2
(en)
|
2015-04-01 |
2020-08-11 |
Cedars-Sinai Medical Center |
Anti-methanogenic lovastatin analogs or derivatives and uses thereof
|
CA2983272C
(en)
|
2015-05-01 |
2023-08-29 |
Massachusetts Institute Of Technology |
Triggerable shape memory induction devices
|
WO2017070612A1
(en)
|
2015-10-23 |
2017-04-27 |
Lyndra, Inc. |
Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
|
CN108697649A
(zh)
|
2015-12-08 |
2018-10-23 |
林德拉有限公司 |
用于胃驻留系统的几何构型
|
RU2745992C2
(ru)
*
|
2016-04-25 |
2021-04-05 |
Джелесис ЭлЭлСи |
Способ лечения запора
|
CN117482062A
(zh)
|
2016-05-06 |
2024-02-02 |
雀巢产品有限公司 |
缬草组合物和相关方法
|
JP6780412B2
(ja)
*
|
2016-09-28 |
2020-11-04 |
ライオン株式会社 |
コーティング組成物ならびにコーティング製剤及びその製造方法
|
CN110022861A
(zh)
|
2016-09-30 |
2019-07-16 |
林德拉有限公司 |
用于金刚烷类药物缓释的胃驻留系统
|
US10940113B2
(en)
*
|
2017-02-24 |
2021-03-09 |
Medical And Pharmaceutical Industry Technology And Development Center |
Pharmaceutical composition for colon targeting, method for treating a colon-related disease using the same and preparation method thereof
|
AU2018279853A1
(en)
*
|
2017-06-09 |
2020-01-02 |
Lyndra Therapeutics, Inc. |
Gastric residence systems with release rate-modulating films
|
WO2019217601A1
(en)
*
|
2018-05-08 |
2019-11-14 |
Protz Jonathan M |
Methods and compositions for drug targeted delivery
|
US11826437B2
(en)
*
|
2020-10-19 |
2023-11-28 |
The Procter & Gamble Company |
Oral care article comprising a hydrophobic delivery carrier and solid hydrophilic particle comprising a bleaching agent
|
CN114224860B
(zh)
*
|
2021-11-06 |
2023-04-28 |
山东润德生物科技有限公司 |
氨基葡萄糖钙片制剂及其制备方法与应用
|